Collaborates with the Medical Affairs Director, Solid Tumors TA Lead to develop Medical Affairs strategic plans aligned with brand strategic imperatives and informed by external engagement, MSL and cross-functional input, and actionable insights, supporting data generation, scientific communication, education, and stakeholder awareness. Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS.